Search

Search Results

• 

  The scientific targets: the myocardium, the vasculature and the body’s response to heart failure

  Rafael Vidal-Pérez, Ewa A. Jankowska

  2024-03-28

  Published: March 28, 2024

  2168

  PDF: 71

  HTML: 14
• 

  Evolving targets for heart failure: the journey so far

  Giuseppe M.C. Rosano, Jerneja Farkas

  2023-11-28

  Published: November 28, 2023

  1473

  pdf: 117

  HTML: 3
• 

  Clinical trial design, endpoints and regulatory considerations in heart failure

  Giuseppe M.C. Rosano

  2024-03-28

  Published: March 28, 2024

  5092

  PDF: 218

  HTML: 68
• 

  Adherence to lifestyle therapy in patients with chronic heart failure and comorbidity

  Elena Efremova, Alexander Shutov

  2023-12-20

  Published: December 20, 2023

  730

  pdf: 79

  HTML: 4
• 

  Iron deficiency in heart failure with preserved ejection fraction: rationale and design of the FAIR-HFpEF trial

  Stephan von Haehling, Wolfram Doehner, Ruben Evertz, Tania Garfias-Veitl, Monika Diek, Mahir Karakas, Ralf Birkemeyer, Gerasimos Fillippatos, Piotr Ponikowski, Michael Böhm, Tim Friede, Stefan D. Anker

  2023-12-27

  Published: December 27, 2023

  1737

  pdf: 279

  HTML: 9
• 

  Defining iron replete status in patients with heart failure treated with intravenous iron

  Khawaja M. Talha, Javed Butler, Stephan von Haehling, Mitja Lainscak, Piotr Ponikowski, Stefan D. Anker

  2023-12-21

  Published: December 21, 2023

  2003

  pdf: 137

  HTML: 28
• 

  Detection of early heart failure with preserved ejection fraction in metabolic syndrome patients detected as part of a national screening program in middle aged subjects

  Jelena Čelutkienė, Agnė Monika Jakštaitė, Jolita Badarienė, Svetlana Solovjova, Ieva Slivovskaja, Rokas Navickas, Edita Kazėnaitė, Egidija Rinkūnienė, Alma Čypienė, Jonas Misiūra, Ligita Ryliškytė, Aleksandras Laucevičius, Andrew J.S. Coats

  2023-12-29

  Published: December 29, 2023

  970

  pdf: 83

  HTML: 1
• 

  Intervention options: depression and cardiovascular disease during COVID-19

  Eirini Flouda, Athena Stefanatou, Tinia Apergi

  2023-11-28

  Published: November 28, 2023

  1319

  pdf: 97

  HTML: 2
• 

  SGLT2 inhibitors and risk reduction for mortality in high-risk patients: a meta-analysis of randomized controlled trials

  Tariq Jamal Siddiqi, Javed Butler, Andrew J.S. Coats, Subodh Verma, Tim Friede, Gerasimos Filippatos, Stefan D. Anker

  2023-11-23

  Published: November 23, 2023

  685

  pdf: 121

  Supplementary Material: 19

  HTML: 17
• 

  Elevated left ventricular end diastolic pressure, chronic pulmonary oedema and valve disease

  Prithwish Banerjee

  2024-04-08

  Published: April 8, 2024

  701

  PDF: 36

  HTML: 51
• 

  Rationale and design for the peripartum cardiomyopathy in Nigeria (PEACE) registry

  Kamilu M. Karaye, Idris Y. Mohammed, Okechukwu S. Ogah, Basil N. Okeahialam

  2023-11-28

  Published: November 28, 2023

  616

  pdf: 92

  HTML: 8
• 

  Exercise capacity, iron deficiency and depressive symptoms in patients with asymptomatic chronic systolic heart failure

  Sven Christopher Aland, Christoph Gertler, Hannah Leonie Bräunig, Timo Schröder, Frank Edelmann, Rolf Wachter, Christoph Herrmann-Lingen, Gerd Hasenfuß, Anja Sandek

  2024-06-28

  Published: June 28, 2024

  1060

  PDF: 321
• 

  Anomalous origin of right coronary artery from the pulmonary artery: an incidental finding on cardiac computed tomography in a patient presenting with dyspnea

  Rachel Anne Xuereb, Sara Xuereb, Kentaro Yamagata, Robert George Xuereb

  2024-03-28

  Published: March 28, 2024

  731

  PDF: 75

  HTML: 11
• 

  The effect of SGLT2 inhibitors on health status in patients with heart failure: a systematic review and meta-analysis

  Muhammad Shariq Usman, Arsalan Hamid, Shurjeel Uddin Qazi, Mikhail N. Kosiborod, Deepak L. Bhatt, Muhammad Shahzeb Khan, Muthiah Vaduganathan, Javed Butler

  2024-06-28

  Published: June 28, 2024

  1716

  PDF: 467

  Conflict of interest: 256

  SUPPLEMENTARY MATERIAL: 234